Overview


According to FutureWise analysis the market for Latin America PoC Diagnostics in 2023 is US$ 3.55 billion, and is expected to reach US$ 6.34 billion by 2031 at a CAGR of 7.52%.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Latin America PoC Diagnostics Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Latin America PoC Diagnostics Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.
  • Alere Inc.
  • Quidel Corporation
  • F. Hoffmann-La Roche Ltd
  • Danaher Corporation
  • Thermo Fisher Scientific
  • bioMérieux S.A.
  • Becton, Dickinson and Company
  • Chembio Diagnostics
  • Johnson & Johnson
  • Siemens Healthineers GmbH
  • PTS Diagnostics
  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • OraSure Technologies Inc.
  • Abaxis Inc

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Product

  • Blood Glucose Monitoring Testing Products
    • Strips
    • Meters
    • Lancets and Lancing Devices
  • Cardiac Metabolism Monitoring Testing Products
    • Blood Gas/Electrolytes Testing Products
    • Cardiac Markers
    • Hba1c Testing Products
  • Infectious Disease Testing Products
    • Influenza Testing Products
    • HIV Testing Products
    • Hepatitis C Testing Products
    • Sexually Transmitted Disease (STD) Testing Products
    • Healthcare Associated Infection (HAI) Testing Products
    • Respiratory Infection Testing Products
    • Tropical Disease Testing Products
    • Other Infectious Disease Testing Products
  • Coagulation Monitoring Products
    • Prothrombin Time (PT/INR) Testing Products
    • Activated Clotting Time (ACT/aPTT) Testing Products
  • Pregnancy and Fertility Testing Products
    • Pregnancy Testing Products
    • Fertility Testing Products
  • Fecal Occult Testing Products
  • Hematology Testing Products
  • Tumor/Cancer Markers Testing Products
  • Drugs of Abuse Testing Products
  • Urinalysis Testing Products
  • Cholesterol Testing Products
  • Other PoC Testing Products

By Platform

  • Lateral Flow Assays (Immunochromatography Tests/Lateral Flow Immunoassays)
  • Dipsticks
  • Microfluidics
  • Molecular Diagnostics

By Mode

  • Prescription-Based Testing Products
  • Over-the-Counter (OTC) Testing Products

By End User

  • Home Care/Self Testing
  • Physician offices and Outpatient/Ambulatory Care Settings
  • Hospitals
  • Research Laboratories

By Region

  • Brazil
  • Venezuela
  • Argentina
  • Rest of Latin America
  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants
  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth
  • To provide with an exhaustive analysis on the Latin America PoC Diagnostics Market By Product, By Platform, By Mode, By End User and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— Brazil, Venezuela, Argentina, Rest of Latin America
  • To record and evaluate competitive landscape mapping- Product launches, technological advancements, mergers and expansions
  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1 . Years Considered for the Study
         3.2 . Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1 . Secondary Data
          1.1.1 . Key Data from Secondary Sources
         1.2 . Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Latin America PoC Diagnostics Market Variables, Trends and Scope

    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Latin America PoC Diagnostics Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Latin America PoC Diagnostics Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Latin America PoC Diagnostics Market, By Product Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Blood Glucose Monitoring Testing Products
         1.1. Strips
         1.2. Meters
         1.3. Lancets and Lancing Devices
        2. Cardiac Metabolism Monitoring Testing Products
         2.1. Blood Gas/Electrolytes Testing Products
         2.2. Cardiac Markers
         2.3. Hba1c Testing Products
        3. Infectious Disease Testing Products
         3.1. Influenza Testing Products
         3.2. HIV Testing Products
         3.3. Hepatitis C Testing Products
         3.4. Sexually Transmitted Disease (STD) Testing Products
         3.5. Healthcare Associated Infection (HAI) Testing Products
         3.6. Respiratory Infection Testing Products
         3.7. Tropical Disease Testing Products
         3.8. Other Infectious Disease Testing Products
        4. Coagulation Monitoring Products
         4.1. Prothrombin Time (PT/INR) Testing Products
         4.2. Activated Clotting Time (ACT/aPTT) Testing Products
        5. Pregnancy and Fertility Testing Products
         5.1. Pregnancy Testing Products
         5.2. Fertility Testing Products
        6. Fecal Occult Testing Products
        7. Hematology Testing Products
        8. Tumor/Cancer Markers Testing Products
        9. Drugs of Abuse Testing Products
        10. Urinalysis Testing Products
        11. Cholesterol Testing Products
        12. Other PoC Testing Products

  • 8.   Latin America PoC Diagnostics Market, By Platform Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Lateral Flow Assays (Immunochromatography Tests/Lateral Flow Immunoassays)
        2. Dipsticks
        3. Microfluidics
        4. Molecular Diagnostics

  • 9.   Latin America PoC Diagnostics Market, By Mode Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Prescription-Based Testing Products
        2. Over-the-Counter (OTC) Testing Products

  • 10.   Latin America PoC Diagnostics Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Home Care/Self Testing
        2. Physician offices and Outpatient/Ambulatory Care Settings
        3. Hospitals
        4. Research Laboratories

  • 11.   Latin America PoC Diagnostics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Market Share Analysis and Competitive Landscape
    •   1. Latin America Landscape - Key Players, Revenue and Presence
        2. Latin AmericaShare Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Latin America Emerging Companies
        4. Latin America - Market Share Analysis and Key Regional Players
        5. Latin America Key Player - Growth Matrix
  • 13.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)

    •   1. Alere Inc.
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Quidel Corporation
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. F. Hoffmann-La Roche Ltd
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Danaher Corporation
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Thermo Fisher Scientific
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. bioMérieux S.A.
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Becton, Dickinson and Company
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Chembio Diagnostics
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Johnson & Johnson
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Siemens Healthineers GmbH
         10.1.Company Overview
         10.2.Product Portfolio
         10.3.SWOT Analysis
         10.4.Financial Overview
         10.5.Strategic Overview
        11. PTS Diagnostics
         11.1.Company Overview
         11.2.Product Portfolio
         11.3.SWOT Analysis
         11.4.Financial Overview
         11.5.Strategic Overview
        12. Abbott Laboratories
         12.1.Company Overview
         12.2.Product Portfolio
         12.3.SWOT Analysis
         12.4.Financial Overview
         12.5.Strategic Overview
        13. Agilent Technologies, Inc.
         13.1.Company Overview
         13.2.Product Portfolio
         13.3.SWOT Analysis
         13.4.Financial Overview
         13.5.Strategic Overview
        14. OraSure Technologies Inc.
         14.1.Company Overview
         14.2.Product Portfolio
         14.3.SWOT Analysis
         14.4.Financial Overview
         14.5.Strategic Overview
        15. Abaxis Inc
         15.1.Company Overview
         15.2.Product Portfolio
         15.3.SWOT Analysis
         15.4.Financial Overview
         15.5.Strategic Overview

  • 14.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 15.   FutureWise SME Key Takeaway Points for Client

Ask for Discount
Buy Now
Customize This Report
  • We Offer Special Discounts for start-ups, NGOs, and Educational & Research institutions.

Need Assistance

  • UK : +44 141 628 9353
  • US : +1 347 709 4931

What you get

  • Excel Dataset
  • Market Overview
  • Infographics
  • PowerPoint Presentation
  • PDF Report

What's included

  • Consumer Perception and Procurement
  • Market Data Forecast
  • Competitive Analysis
  • Risks and Opportunity Assessment
  • Market Trends and Dynamics
Partner

Our Clients

image0
image1
image2
image3
image4
image5
image6
image7
image8
image9
image10
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11